FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is a method for predicting severe acute necrotizing pancreatitis by determining the concentration of a marker in the serum of venous blood, characterized in that the concentration of transthyretin in the serum of venous blood is used as a marker, venous blood is taken on the 5–7th day from the moment of the disease, then, according to the concentration of transthyretin in the serum of the venous blood, the type of the disease is predicted, transthyretin value <14 mg/dl, the development of severe acute necrotizing pancreatitis is predicted.
EFFECT: invention provides fast and accurate prediction of severe acute necrotizing pancreatitis.
1 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE OUTCOME OF THE DISEASE IN THERAPEUTIC PATIENTS OF THE INTENSIVE CARE UNIT | 2020 |
|
RU2742519C1 |
| METHOD FOR PREDICTION OF SEVERE ACUTE PANCREATITIS BY ENERGY BALANCE | 2024 |
|
RU2835128C1 |
| METHOD FOR PREDICTION OF FATAL OUTCOME IN ACUTE PANCREATITIS BY NITROGEN BALANCE | 2024 |
|
RU2836522C1 |
| METHOD FOR PREDICTION OF SEVERE ACUTE PANCREATITIS BY URINE NITROGEN EXCRETION | 2024 |
|
RU2836535C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF STERILE AND INFECTED PANCREATITIS | 2022 |
|
RU2793647C1 |
| PREDICTION METHOD OF ACUTE PANCREATITIS OUTCOME | 2007 |
|
RU2338195C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF UREMIC PANCREATITIS AND DESTRUCTIVE PANCREATITIS IN PATIENTS RECEIVING RENAL REPLACEMENT THERAPY - PROGRAM HEMODIALYSIS | 2020 |
|
RU2761730C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF UREMIC PANCREATITIS AND DESTRUCTIVE PANCREATITIS IN PATIENTS RECEIVING RENAL REPLACEMENT THERAPY - PROGRAM HEMODIALYSIS | 2020 |
|
RU2761733C1 |
| METHOD FOR PREDICTION OF PANCREATIC NECROSIS ACCOMPANYING ACUTE PANCREATITIS | 2024 |
|
RU2840954C1 |
| METHOD FOR PREDICTING THE SEVERITY OF ACUTE PANCREATITIS AT AN EARLY STAGE BASED ON SIGNS OF HEPATODEPRESSION | 2017 |
|
RU2676331C1 |
